Detail akcie Intuitive Surgical online

Business Summary: Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Intuitive Surgical Inc revenues increased 23% to $2.77B. Net income increased 18% to $821.5M. Revenues reflect Instruments and accessories segment increase of 23% to $1.69B, Systems segment increase of 24% to $650.7M, Outside of United states segment increase of 38% to $987.5M, U.S. segment increase of 16% to $1.78B. Net income was partially offset by Selling.